the subject of the invention is a new compound n - (1 - oksylo - 2,2,6,6 - tetrametylopiperidyn - 4 - yl) pyridine - 3 - karboksyamid of formula 1, its use in the treatment of cancer and the way of receiving that acid 3 - pirydylokarboksylowy in the form of a hydrochloride solution in anhydrous r ozpuszczalniku undergo reaction with 4 - amino - 2,2,6,6 - tetrametylopiperydylo - 1 - oksylem,known as the tempamina, previously purified by using column chromatography, followed by vacuum distillation tempaminy corresponding fraction. the reaction of 3 - pirydylokarboksylowego hydrochloride with tempamin\u0105 used in quantities r\u00f3wnomolowych, leads in the presence of n, n-dimethylformamide as catalyst, the intense stirring and sonikuj\u0105c.then the obtained mixture poreakcyjnej ethanolic solution is added or aqueous ethanolic solution of sodium hydroxide or potassium hydroxide and l-ascorbic acid, and the mixture of solvents are vaporized vacuum and obtained sludge dissolves in distilled water after fixed ph aqueous solution in the range from 7 to 9 by adding carbon dioxidesubsequently, the resulting mixture is subjected to continuous extraction with diethyl ether and the ether extract is vaporized, the n - (1 - hydroxy - 2,2,6,tetrametylopiperidyn - 6 - 4 - yl) pyridine - 3 - karboksyamid dissolves in water and subjected to a treatment by dotlenienie acetate in the presence of copper (ii) passing the solution gas oxygen or air and maintaining the ph of the solution within the 7 - 9.formed product of formula 1 shall be in the form of a solution eterowego by extraction with aqueous solution at ph 7 - 9 with diethyl ether, after which combined extracts vaporized to diethyl ether.Przedmiotem wynalazku jest nowy związek N-(1-oksylo-2,2,6,6-tetrametylopiperidyn-4-yl)pirydyny-3- karboksyamid o wzorze 1, jego zastosowanie w leczeniu chorób nowotworowych oraz sposób otrzymywania polegający na tym, że kwas 3-pirydylokarboksylowy w postaci roztworu chlorowodorku w bezwodnym
